HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A retrospective analysis of the risk factors for allergic reactions induced by the administration of oxaliplatin.

Abstract
This study retrospectively investigated the clinical features and risk factors of allergic reactions induced by oxaliplatin administration. This study investigated the incidence of allergic reactions and analysed the background and laboratory data in patients with colorectal cancer treated with oxaliplatin-based chemotherapy at Kyushu Medical Center between April 2012 and September 2012. A total of 62 patients were included in this study. The number of patients in the allergic and non-allergic groups was 7 and 55 respectively. The incidence of allergic reactions was 11.3%. We compared the patients' characteristics and laboratory data between the two groups and found that the average dose of dexamethasone in the allergic group was significantly lower than that observed in the non-allergic group (P = 0.0111). Furthermore, the incidence of allergic reactions in the group that received prophylaxis of less than 12 mg of dexamethasone was significantly higher than that observed in the group that received more than 12 mg of dexamethasone (P = 0.0103). In conclusion, a lower dexamethasone dose is a possible risk factor for allergic reactions induced by the administration of oxaliplatin; however, given the retrospective design used in this study, further validation of this finding is warranted.
AuthorsH Yamauchi, T Goto, K Takayoshi, K Sagara, M Uoi, C Kawanabe, M Matsunaga, T Miyoshi, K Uchino, N Misumi, T Nishino
JournalEuropean journal of cancer care (Eur J Cancer Care (Engl)) Vol. 24 Issue 1 Pg. 111-6 ( 2015) ISSN: 1365-2354 [Electronic] England
PMID24304429 (Publication Type: Comparative Study, Journal Article)
Copyright© 2013 John Wiley & Sons Ltd.
Chemical References
  • Antineoplastic Agents
  • Glucocorticoids
  • Organoplatinum Compounds
  • Oxaliplatin
  • Dexamethasone
Topics
  • Adult
  • Aged
  • Aged, 80 and over
  • Antineoplastic Agents (administration & dosage, adverse effects)
  • Colorectal Neoplasms (blood, drug therapy)
  • Dexamethasone (administration & dosage)
  • Drug Hypersensitivity (epidemiology, etiology, prevention & control)
  • Female
  • Glucocorticoids (administration & dosage)
  • Humans
  • Incidence
  • Japan (epidemiology)
  • Male
  • Middle Aged
  • Organoplatinum Compounds (administration & dosage, adverse effects)
  • Oxaliplatin
  • Retrospective Studies
  • Risk Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: